NCT06863402
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +20 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,960 public trials
1,827 recruiting studies
Lymphatic Diseases trial results
NCT06471738
- Conditions
- Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage III Follicular Lymphoma, Ann Arbor Stage IV Follicular Lymphoma, +13 more
- Locations
-
- Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital Beijing, China
Recruiting
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
NCT06176690
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, +17 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
NCT03011814
- Conditions
- Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT07218341
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Mitchell Cancer Institute Mobile, Alabama, United States
- Arizona Oncology Associates, P.C. - HOPE Tucson, Arizona, United States
- Cancer Specialists, LLC Jacksonville, Florida, United States
- Minnesota Oncology Hematology, P.A. Coon Rapids, Minnesota, United States
NCT07387926
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Novartis Investigative Site Ramat Gan, Israel
Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
NCT06549595
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Research Site Huntsville, Alabama, United States
- Research Site Anchorage, Alaska, United States
- Research Site Phoenix, Arizona, United States
- Research Site Clovis, California, United States
- Conditions
- Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Bone Marrow Diseases, +22 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07098364
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +20 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07082803
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Stanford Medicine Cancer Center Palo Alto, California, United States
- The START Center for Cancer Care - Midwest Grand Rapids, Michigan, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center New York, United States